1. Suntharalingam G, Perry MR, Ward S, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med. 2006;355:1018–1028.
2. Temporary Specialist Scientific Committee (TSSC). Minutes of the TSSC meeting on “FAAH (Fatty Acid Amide Hydrolase) Inhibitors,” February 15–March 7, 2016.
3. WMA. World Medical Association: Declaration of Helsinki—Ethical Principles for Medical Research Involving Human Subjects. Amended by the 64th WMA General Assembly, Fortaleza, Brazil, October 2013.
4. Sibille M, Donazzolo Y, Lecoz F, Krupka E. After the London tragedy, is it still possible to consider Phase I is safe? Br J Clin Pharmacol. 2006;62:502–503.
5. Mezher M. EMA begins review of first-in-human trial safety following patient death, 2016. http://www.raps.org/Regulatory-Focus/News/2016/05/27/25030/EMA-Begins-Review-of-First-in-Human-Trial-Safety-Following-Patient-Death/. Accessed November 7, 2016.